Cart (0 Items)
Your cart is currently empty.
View ProductsStable Isotope Labelled Trastuzumab Biosimilar – Anti-HER2 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Isotope Labelled Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade |
|---|---|
| Source | DrugBank DB00072 |
| Species | Human |
| Expression system | Mammalian cells |
| Molecular weight | 145kDa |
| Purity | >95% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Applications | MS |
| Aliases /Synonyms | Trastuzumab |
| Reference | PX-TA1005-SIL |
| Related Products | PX-P4120 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1 |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
| Formula | C6470H10012N1726O2013S42 |
Description of Stable Isotope Labelled Trastuzumab Biosimilar - Anti-HER2 mAb - Research Grade
General information about Trastuzumab
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research. This product is for research use only.
Reviews
Il n’y a pas encore d’avis.